Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-19

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a generic dexmethylphenidate hydrochloride product from Ascend Laboratories for the treatment of attention-deficit/hyperactivity disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)